BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol 2015; 7(2): 245-252 [PMID: 25729479 DOI: 10.4254/wjh.v7.i2.245]
URL: https://www.wjgnet.com/1948-5182/full/v7/i2/245.htm
Number Citing Articles
1
Ying Zhang, Tao Li, Yumin Qiu, Tao Zhang, Pengbo Guo, Xiaomin Ma, Qing Wei, Lihui Han. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinomaMedicine 2017; 96(2): e5642 doi: 10.1097/MD.0000000000005642
2
Michelle Ju, Adam C. Yopp. The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?Cancers 2019; 11(10): 1441 doi: 10.3390/cancers11101441
3
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinomaScandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
4
Guang‐Tao Min, Yu‐Min Li, Nan Yao, Jun Wang, Hong‐Peng Wang, Wei Chen. The pretreatment neutrophil‐lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta‐analysisClinical Transplantation 2018; 32(1) doi: 10.1111/ctr.13151
5
Xiaoqin Wu, Bin Zhao, Yahui Cheng, Yang Yang, Cheng Huang, Xiaoming Meng, Baoming Wu, Lei Zhang, Xiongwen Lv, Jun Li. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cellsToxicology and Applied Pharmacology 2015; 288(1): 74 doi: 10.1016/j.taap.2015.07.010
6
Keunyoung Kim, Seong-Jang Kim. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysisClinical Imaging 2021; 79: 251 doi: 10.1016/j.clinimag.2021.06.015
7
Horatio R. Thomas, Mary Feng. Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular CarcinomaCurrent Hepatology Reports 2021; 20(1): 12 doi: 10.1007/s11901-020-00559-1
8
Marwa Matboli, Ayman E Shafei, Mahmoud A Ali, Ahmed M Ashry, Kamal M Kamal, Mohammed Ali Agag, Ibrahim Reda, Eman Fathy Tash, Marwa Ali. circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinomaJournal of Cellular Biochemistry 2019; 120(5): 7711 doi: 10.1002/jcb.28045
9
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approachesNature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
10
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng, Sung-Hsin Kuo. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectivenessWorld Journal of Gastrointestinal Oncology 2019; 11(8): 579-588 doi: 10.4251/wjgo.v11.i8.579
11
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
12
Yuan Zhang, Min Ding, Jia-chang Chi, Tao Wang, Yao-ping Shi, Bo Zhai. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinomaBrachytherapy 2019; 18(5): 733 doi: 10.1016/j.brachy.2019.05.011
13
Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku. Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case reportSurgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0178-x
14
Yanyan Qian, Hongmeng Su, Yanping Ge, Kai Lei, Yiping Li, Hong Fan. Prognostic Value of Pd-L1 Expression Combined with Hypoxia-Associated Immunosuppression in Hepatocellular CarcinomaBiomarkers in Medicine 2022; 16(6): 435 doi: 10.2217/bmm-2021-1051
15
Yujia Xia, Zachary J. Brown, Hai Huang, Allan Tsung. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinomaCancer Medicine 2021; 10(18): 6374 doi: 10.1002/cam4.4177
16
Zheng-Guang Xu, Cheng-Jie Ye, Lin-Xun Liu, Gang Wu, Zhan-Xue Zhao, Yong-Zhen Wang, Bing-Qiang Shi, Yong-Hong Wang. The Pretransplant Neutrophil-Lymphocyte Ratio as a New Prognostic Predictor After Liver Transplantation For Hepatocellular Cancer: a Systematic Review and Meta-analysisBiomarkers in Medicine 2018; 12(2): 189 doi: 10.2217/bmm-2017-0307
17
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – LangversionZeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
18
Alyson P Black, Anand S Mehta. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcomeCurrent Opinion in Pharmacology 2018; 41: 74 doi: 10.1016/j.coph.2018.04.002
19
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular CarcinomaCureus 2020;  doi: 10.7759/cureus.9191
20
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian PerspectiveDigestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
21
Anuradha Budhu, Xin Wei Wang. Hepatocellular Carcinoma2016; : 93 doi: 10.1007/978-3-319-34214-6_5
22
H.Y.-h. Liu, Y.-y.D. Lee, S. Sridharan, W. Wang, R. Khor, J. Chu, A. Oar, E.S. Choong, H. Le, M. Shanker, A. Wigg, K. Stuart, D. Pryor. Definitive Stereotactic Body Radiation Therapy in Early-Stage Solitary Hepatocellular Carcinoma: An Australian Multi-Institutional Review of OutcomesClinical Oncology 2023; 35(12): 787 doi: 10.1016/j.clon.2023.08.012
23
Jian-Feng Yang, Zhen-Hua Zhao, Yu Zhang, Li Zhao, Li-Ming Yang, Min-Ming Zhang, Bo-Yin Wang, Ting Wang, Bao-Chun Lu. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(13): 3652-3662 doi: 10.3748/wjg.v22.i13.3652
24
Soo‐Ho Lee, Jun‐Suh Lee, Gun‐Hyung Na, Young‐Kyoung You, Dong‐Goo Kim. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantationClinical Transplantation 2017; 31(1) doi: 10.1111/ctr.12852
25
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, Genki Tanaka, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Masato Kato, Taku Aoki, Keiichi Kubota. The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinomaJournal of Surgical Oncology 2017; 116(8): 1166 doi: 10.1002/jso.24772
26
Christian P. Strassburg. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Visceral Medicine 2016; 32(4): 263 doi: 10.1159/000446385
27
Gloria Y. Chang, Adam C. Yopp. Expanding Indications for Surgical Resection in Hepatocellular CarcinomaSurgical Oncology Clinics of North America 2024; 33(1): 99 doi: 10.1016/j.soc.2023.07.004
28
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experienceAnnals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
29
Ahmed Omar Kaseb, Luis Vence, Jorge Blando, Shalini S. Yadav, Naruhiko Ikoma, Roberto Carmagnani Pestana, Jean Nicolas Vauthey, James P. Allison, Padmanee Sharma. Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaCancer Immunology Research 2019; 7(9): 1390 doi: 10.1158/2326-6066.CIR-18-0605
30
Satoshi Omiya, Takeshi Urade, Shohei Komatsu, Masahiro Kido, Kaori Kuramitsu, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto. Impact of GLIM criteria-based malnutrition diagnosis on outcomes following liver resection for hepatocellular carcinomaHPB 2023; 25(12): 1555 doi: 10.1016/j.hpb.2023.08.012
31
Po-Lung Cheng, Ping-Hsiu Wu, We-Yu Kao, Yen-Ting Lai, Jason C. Hsu, Jeng-Fong Chiou, Meng-Huang Wu, Hsin-Lun Lee. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysisExperimental Hematology & Oncology 2023; 12(1) doi: 10.1186/s40164-023-00400-7
32
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
33
Keisuke Arai, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysisSurgery Today 2017; 47(3): 385 doi: 10.1007/s00595-016-1384-7
34
Jasmin Zeindler, Gabriel Fridolin Hess, Maximilian von Heesen, Noa Aegerter, Cornelia Reber, Andreas Michael Schmitt, Simone Muenst, Martin Bolli, Savas Deniz Soysal, Otto Kollmar. Anatomic versus non‐anatomic liver resection for hepatocellular carcinoma—A European multicentre cohort study in cirrhotic and non‐cirrhotic patientsCancer Medicine 2024; 13(5) doi: 10.1002/cam4.6981
35
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
36
Oliver John Kennedy, Paul Roderick, Ryan Buchanan, Jonathan Andrew Fallowfield, Peter Clive Hayes, Julie Parkes. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysisBMJ Open 2017; 7(5): e013739 doi: 10.1136/bmjopen-2016-013739
37
Francesco Vasuri, Michela Visani, Giorgia Acquaviva, Thomas Brand, Michelangelo Fiorentino, Annalisa Pession, Giovanni Tallini, Antonia D’Errico, Dario de Biase. Role of microRNAs in the main molecular pathways of hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(25): 2647-2660 doi: 10.3748/wjg.v24.i25.2647
38
Po-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, Jen-Fu Yang, Meei-Shyuan Lee, Yang-Hong Dai, Chun-Shu Lin, Chao-Yueh Fan, Wen-Yen Huang. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaInternational Journal of Radiation Oncology*Biology*Physics 2019; 105(2): 307 doi: 10.1016/j.ijrobp.2019.05.066
39
Nicole Nevarez, Adam Yopp. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusJournal of Hepatocellular Carcinoma 2021; : 851 doi: 10.2147/JHC.S291530
40
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter, Malek Nisar. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären KarzinomsZeitschrift für Gastroenterologie 2022; 60(01): e56 doi: 10.1055/a-1589-7568
41
Po-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, Cheng-Hsiang Lo, Jen-Fu Yang, Yu-Fu Su, Ying-Fu Wang, Chia-Feng Lu, Chun-Shu Lin. Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body RadiotherapyBiomedicines 2022; 10(3): 597 doi: 10.3390/biomedicines10030597
42
Shohei Okazaki, Kei Shibuya, Shintaro Shiba, Tomoyuki Takura, Tatsuya Ohno. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular CarcinomaAdvances in Radiation Oncology 2024; 9(4): 101441 doi: 10.1016/j.adro.2024.101441
43
Connor A. West, Alyson P. Black, Anand S. Mehta. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 93 doi: 10.1007/978-3-030-21540-8_5
44
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
45
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysisInternational Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
46
G.K. Glantzounis, E. Tokidis, S.-P. Basourakos, E.E. Ntzani, G.D. Lianos, G. Pentheroudakis. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic reviewEuropean Journal of Surgical Oncology (EJSO) 2017; 43(1): 32 doi: 10.1016/j.ejso.2016.05.026
47
Yu-De Chu, Hsin-Yu Lai, Li-Mei Pai, Ya-Hui Huang, Yang-Hsiang Lin, Kung-Hao Liang, Chau-Ting Yeh. The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionineCell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1486-4
48
Lior Charach, Zusmanovitch Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 3: Surgical and Medical TreatmentEMJ Hepatology 2017; : 89 doi: 10.33590/emjhepatol/10312792
49
Yu-De Chu, Hui-Fen Liu, Yi-Chen Chen, Chun-Hung Chou, Chau-Ting Yeh. WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.996820
50
Yufei Tian, Wei Yao, Dongyun He, Yingying Xu, Yiquan Li, Yilong Zhu, Jinbo Fang, Bing Bai, Xiao Li, Lili Sun, Ningyi Jin. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitroAnti-Cancer Drugs 2020; 31(2): 110 doi: 10.1097/CAD.0000000000000854
51
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
52
Hae Won Lee, Kyung-Suk Suh. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinomaCurrent Opinion in Organ Transplantation 2016; 21(2): 231 doi: 10.1097/MOT.0000000000000294
53
Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T. Locklear, Zobair M. Younossi. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesMedicine 2017; 96(9): e5904 doi: 10.1097/MD.0000000000005904
54
Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cellsCell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05419-y
55
HJ Lim, AKH Chiow, LS Lee, SS Tan, BKP Goh, YX Koh, CY Chan, SY Lee. Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imagingSingapore Medical Journal 2021; 62(4): 182 doi: 10.11622/smedj.2019137
56
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
57
Jin Shang, Shanling Xu, Jiaxing Zhang, Xuting Ran, Lang Bai, Hong Tang. Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysisOncotarget 2017; 8(65): 109723 doi: 10.18632/oncotarget.21299
58
Xionghu Shen, Xian Cui, Hai Cui, Yongmin Jin, Wenbiao Jin, Honghua Sun. Geraniol and lupeol inhibit growth and promote apoptosis in human hepatocarcinoma cells through the MAPK signaling pathwayJournal of Cellular Biochemistry 2019; 120(4): 5033 doi: 10.1002/jcb.27779